ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,446, issued on Jan. 13, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).
"Anti-CEACAM5 antibody drug conjugates" was invented by Nicole Vincent Jordan (Needham, Mass.), Ruchira Dasgupta (Auburndale, Mass.), Lore Florin (Redwood City, Calif.), Derek Giuliana (Ashland, Mass.), Raphael Levy (Belmont, Calif.), Carrie J. Marshall (Walpole, Mass.), Thomas McDonagh (Charlestown, Mass.), Akbar Nayeem (Newtown, Pa.), Sayumi Yamazoe (Mountain View, Calif.) and Hong Zhang (Belmont, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are antibody drug conjugates of the formula (I) comprising an anti-CEACAM5 antibodies, antigen bindin...